Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine plus capecitabine in refractory advanced colorectal cancer
NCT01097018Phase 3Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Apr 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perifosine in colorectal cancer (CRC), sponsored by COSCIENS Biopharma Inc.. Started Apr 2010; status: completed.
02
Drugs
perifosine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01097018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097018.